Navigation Links
Queensland Facility for Advanced Bioinformatics (QFAB) Becomes a GeneGo Center of Excellence for the Asia Pacific Region

ST. JOSEPH, Mich., Feb. 2 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that QFAB has licensed MetaCore and entered a co marketing agreement with GeneGo for the Asia Pacific region. QFAB will have GeneGo certified experts on staff to run training classes in the region and support the local research community. QFAB will make MetaCore pathway tools, software and manually curated databases accessible to Australian and New Zealand academics as part of its delivery of tailored bioinformatics solutions to life science researchers in the region.

Jeremy Barker, QFAB's Chief Executive Officer said, "We are currently using MetaCore for an in-house project and have seen the power that it provides in a systems biology framework. In partnering with GeneGo we aim to help researchers in our part of the world realize the benefits that can come from using this software."

"We are very excited about this relationship as we will work together to open up and support Australia, New Zealand and beyond," said Julie Bryant, GeneGo's VP of Business development. "We will be jointly supporting a lot of marketing and research activities in the region as there is a lot of exciting and novel research we would like to be involved in."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.2(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 5.2(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.

For more information, please visit the company's web site at

SOURCE GeneGo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Open Biosystems Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland
2. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
3. Novavax Announces Operational Status of Its Vaccine Pilot Plant and Commercial Launch Facility
4. Hovione Buys Pfizers Loughbeg API Facility
5. Updated Pictures of CEL-SCI Manufacturing Facility Available Online
6. Vicenza Hospital Becomes First European Facility to Purchase Its Second CyberKnife System
7. Nikon Instruments Provides Donation to Help Clemson University Start New Core Microscopy Facility
8. BioLife Solutions Credit Facility Increased to $9 Million
9. Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island
10. Blanchette Rockefeller Neurosciences Institute Hosts First-Ever International Forum on Memory and Memory Disorders and Dedicates New $30 Million Research Facility
11. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
Post Your Comments:
(Date:10/12/2015)... 2015 cell surface marker detection market ... according to a new report by Grand View Research, Inc. ... incidence of oncology diseases and other cell-associated disorders. --> ... reach USD 6.49 billion by 2022, according to a new ... can be attributed to rise in incidence of oncology diseases ...
(Date:10/12/2015)... 12, 2015 LabStyle Innovations Corp. ... Solution, today announced its Medical Director, Dr. Moshe ... MobiHealth,s 5th EAI International Conference on Wireless Mobile ... innovations in mobile and wireless technologies," the conference will ... from October 14 - 16, 2015. The conference is ...
(Date:10/12/2015)... ... 2015 , ... NeuMedics Inc., is a specialty biopharmaceutical company focused on identifying ... chronically be administered as an eye drop, announced today it has been selected to ... taking place October 25th to October 28th at The Cleveland Clinic, Cleveland, Ohio. ...
(Date:10/10/2015)... Maryland , 10. Oktober, 2015 ... Matsui (Abgeordnete der Demokratischen Partei für Kalifornien) ihre ... bis 17. Oktober) in die Aufzeichnungen des Kongresses ... Plasma Protein Therapeutics Association (PPTA) und ihren ... , Hebung des Bewusstseins über Plasmaspenden weltweit ...
Breaking Biology Technology:
(Date:9/10/2015)... Pursuant Health has collaborated with health ... interactive, image-based health risk assessment (HRA) optimized for ... unique assessment quantifies user results into an easily ... individual,s biological age based on personal health habits, ... kiosk. Comprised of age, gender, and ...
(Date:9/9/2015)... , Sept. 9, 2015  NuData Security announced ... solution-based milestones, furthering the company,s commitment to protecting ... fraud. NuData Security,s online fraud detection ... company,s growth cycle. The product combines continual analysis ... good user behavior from fraudulent behavior, allowing the ...
(Date:9/8/2015)... , Sept. 8, 2015  Affectiva, global ... Emotion as a Service, a new data solution, ... Based on Affectiva,s highly accurate and patented ... analytics capabilities, slated to transform industries such as ... development, retail, customer experience, online education, HR, automotive, ...
Breaking Biology News(10 mins):